echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > The New Indication Marketing Application of Nuocheng Jianhua Orelabrutinib in the Treatment of Relapsed/Refractory Marginal Zone Lymphoma was Accepted in China

    The New Indication Marketing Application of Nuocheng Jianhua Orelabrutinib in the Treatment of Relapsed/Refractory Marginal Zone Lymphoma was Accepted in China

    • Last Update: 2022-08-20
    • Source: Internet
    • Author: User
    Tags

    mdt drug

    basic food safety
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com